These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14720455)

  • 81. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
    Stewart S; Prince M; Bassendine M; Hudson M; James O; Jones D; Record C; Day CP
    J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Combination of S-adenosylmethionine and Dilinoleoylphosphatidylcholine Attenuates Non-alcoholic Steatohepatitis Produced in Rats by a High-Fat Diet.
    Lieber CS; Leo MA; Cao Q; Mak KM; Ren C; Ponomarenko A; Wang X; Decarli LM
    Nutr Res; 2007 Sep; 27(9):565-573. PubMed ID: 18769506
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Steroids or cocktails for alcoholic hepatitis.
    O'Shea R; McCullough AJ
    J Hepatol; 2006 Apr; 44(4):633-6. PubMed ID: 16503078
    [No Abstract]   [Full Text] [Related]  

  • 84. Treatment of alcoholic liver disease.
    Mezey E
    Semin Liver Dis; 1993 May; 13(2):210-6. PubMed ID: 8337605
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
    Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
    BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
    [TBL] [Abstract][Full Text] [Related]  

  • 86. WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD002235. PubMed ID: 26560497
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Antioxidants as therapeutic agents for liver disease.
    Singal AK; Jampana SC; Weinman SA
    Liver Int; 2011 Nov; 31(10):1432-48. PubMed ID: 22093324
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Current trials and novel therapeutic targets for alcoholic hepatitis.
    Singal AK; Shah VH
    J Hepatol; 2019 Feb; 70(2):305-313. PubMed ID: 30658731
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chronic liver inflammation: clinical implications beyond alcoholic liver disease.
    Park BJ; Lee YJ; Lee HR
    World J Gastroenterol; 2014 Mar; 20(9):2168-75. PubMed ID: 24605015
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies.
    Le MD; Enbom E; Traum PK; Medici V; Halsted CH; French SW
    Exp Mol Pathol; 2013 Oct; 95(2):187-91. PubMed ID: 23886644
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Alcoholic Liver Disease.
    Abittan CS; Lieber CS
    Curr Treat Options Gastroenterol; 1999 Feb; 2(1):72-80. PubMed ID: 11096576
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Alcoholic liver disease.
    Lumeng L; Crabb DW
    Curr Opin Gastroenterol; 2001 May; 17(3):211-20. PubMed ID: 17031162
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Interview: questions to Philippe Mathurin].
    Mathurin P
    Gastroenterol Clin Biol; 2006 Apr; 30(4):560-2. PubMed ID: 16733379
    [No Abstract]   [Full Text] [Related]  

  • 94. Activity of essential phospholipids (EPL) from soybean in liver diseases.
    Gundermann KJ; Kuenker A; Kuntz E; Droździk M
    Pharmacol Rep; 2011; 63(3):643-59. PubMed ID: 21857075
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Current trend: alcoholic liver diseases].
    Naveau S
    Gastroenterol Clin Biol; 2006 Apr; 30(4):550-3. PubMed ID: 16733376
    [No Abstract]   [Full Text] [Related]  

  • 96. Molecular Mechanism Involved in Carotenoid Metabolism in Post-Smolt Atlantic Salmon: Astaxanthin Metabolism During Flesh Pigmentation and Its Antioxidant Properties.
    Schmeisser J; Verlhac-Trichet V; Madaro A; Lall SP; Torrissen O; Olsen RE
    Mar Biotechnol (NY); 2021 Aug; 23(4):653-670. PubMed ID: 34417678
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia.
    Maev IV; Samsonov AA; Palgova LK; Pavlov CS; Shirokova EN; Vovk EI; Starostin KM
    BMJ Open Gastroenterol; 2020; 7(1):e000368. PubMed ID: 32337059
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells.
    Valentino G; Zivko C; Weber F; Brülisauer L; Luciani P
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31842373
    [TBL] [Abstract][Full Text] [Related]  

  • 99. HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice.
    Lee Y; Kwon DJ; Kim YH; Ra M; Heo SI; Ahn WG; Park JR; Lee SR; Kim KH; Kim SY
    PLoS One; 2017; 12(11):e0185134. PubMed ID: 29091708
    [TBL] [Abstract][Full Text] [Related]  

  • 100. In-vivo
    Valkovič L; Chmelík M; Krššák M
    Anal Biochem; 2017 Jul; 529():193-215. PubMed ID: 28119063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.